Extrafine triple therapy delays COPD clinically important deterioration vs ICS/LABA, LAMA, or LABA/LAMA

Extrafine triple therapy delays COPD clinically important deterioration vs ICS/LABA, LAMA, or LABA/LAMA

Dave Singh,1 Leonardo M Fabbri,2,3 Stefano Vezzoli,4 Stefano Petruzzelli,4 Alberto Papi2 1Medicines Evaluation Unit, University of Manchester, Manchester University NHS Foundation Trust, Manchester, UK; 2Section of Cardiorespiratory and Internal Medicine, Department of Medical Sciences, University...

Full description

Bibliographic Details
Main Authors: Singh D, Fabbri LM, Vezzoli S, Petruzzelli S, Papi A
Format: Article
Language:English
Published: Dove Medical Press 2019-02-01
Series:International Journal of COPD
Subjects:
anticholinergics
beta-2 agonists
chronic obstructive pulmonary disease
disease activity
inhaled corticosteroids
Online Access:https://www.dovepress.com/extrafine-triple-therapy-delays-copd-clinically-important-deterioratio-peer-reviewed-article-COPD

Internet

https://www.dovepress.com/extrafine-triple-therapy-delays-copd-clinically-important-deterioratio-peer-reviewed-article-COPD

Similar Items